DIFFERENTIAL DIAGNOSTICS OF BREAST PATHOLOGY USING CONTRAST ENHANCEMENT PATTERNS IN CONTRAST-ENHANCED SPECTRAL MAMMOGRAPHY
PDF (Русский)

Keywords

BREAST CANCER
DUAL-ENERGY CONTRAST-ENHANCED SPECTRAL MAMMOGRAPHY
DIGITAL MAMMOGRAPHY
CONTRAST ENHANCEMENT PATTERNS
BENIGN BREAST LESIONS

How to Cite

Ulyanova, R., Chernaya, A., Krivorotko, P., Novikov, S., Kanaev, S., Artemeva, A., Shevkunov, L., Tyatkov, S., & Danilov, V. (2020). DIFFERENTIAL DIAGNOSTICS OF BREAST PATHOLOGY USING CONTRAST ENHANCEMENT PATTERNS IN CONTRAST-ENHANCED SPECTRAL MAMMOGRAPHY. Voprosy Onkologii, 66(3), 252–261. https://doi.org/10.37469/0507-3758-2020-66-3-252-261

Abstract

Dual-energy contrast-enhanced spectral mammography (CESM) is a new promising method for visualizing pathological changes in breast, which combines digital mammography and a functional assessment of vascularization using intravenous contrast ehnancement. According to accumulated experience CESM is well tolerated by patients and is similar to magnetic resonance imaging with dynamic contrast enhancement (MRI with DCE), but at the same time, CESM is more affordable and can be performed in patients with contraindications for MRI. However, few studies have been conducted to evaluate the role of CESM. In the world literature, interpretation of contrast images is based only on the degree of accumulation of the contrast agent, but we propose a more detailed assessment of the structure of the hypervascular lesions by highlighting the contrast enhancement patterns. Objective: to determine the diagnostic effectiveness of CESM using the contrast enhancement patterns in malignant and benign lesions. Materials and methods. 239 women with suspicious for breast cancer lesions were examined from August 2018 to December 2019. The mean age of the women was 51 years. 322 lesions were revealed, 149 (46.3%) were malignant, 173 (53.7%) were benign. All lesions were histologically confirmed. As a result of the analysis of our data, 9 types of contrast enhancement patterns were distinguished: reticulate, granular, annular, diffuse-spherical, lacunar, cloud-like, heterogeneous-annular, point, cotton-like. Results. Using an additional diagnostic feature - contrast enhancement patterns in lesions, increased the sensitivity of CESM from 91.3% to 98.0% (p=0.26), specificity from 80.3% to 93, 6% (p=0.013), accuracy from 85.4 to 95.7% (p=0.004) in comparison with using of only one feature of contrast enhancement intensity in the differential diagnosis of malignant and benign lesions. Conclusion: thus, this approach of interpreting subtraction images allows to increase the efficiency of CESM in diagnosis of breast cancer.

https://doi.org/10.37469/0507-3758-2020-66-3-252-261
PDF (Русский)

References

Lobbes M.B.I., Smidt M.L., Houwers J. Contrast enhanced mammography: techniques, current results, and potential indications // Clin. Radiology. - 2013. - Vol. 68. - P. 935.

Жолдыбай Ж.Ж., Жакенова Ж.К., Панина А., Кунанбаева Абыкешева А.А. Возможности контрастной спектральной маммографии в диагностике рака молочной железы // Онкология и радиология Казахстана. - 2015. - № 4. - С. 32-33.

Fallenberg E.M, Schmitzberger F.F., Amer H., Ingold-Heppner B., Balleyguier C. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation // Eur Radiol. - 2017. - Vol. 27. - № 7. - P 2752-2764.

Dromain C., Balleyguier C., Adler Gh., Remi Garbay J. S. Delalogec Contrast-enhanced digital mammography // European Journal of Radiology. - 2009. - Vol. 69. - P. 34-42.

Оксанчук Е.А., Колесник А.Ю., Меских Е.В. Контрастная маммография в дифференциальной диагностике заболеваний молочных желез: первые результаты // II Национальный конгресс "Онкология репродуктивных органов: от профилактики и раннего выявления к эффективному лечению" - 2017. - С. 73.

Sprague B.L., Gangnon R.E., Burt V., Trentham-Dietz A., Hampton J.M., Wellman R.D., Kerlikowske K., Miglioretti D.L. Prevalence of mammographically dense breasts in the United States // J Natl Cancer Inst. - 2014. - Vol. 106. - P. 10.

McCormack V.A., dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis // Cancer Epidemiol Biomarkers Prev. - 2006. - Vol. 15. - № 6. - P. 1159-69.

Max M. Hobbs, Donna B. Taylor, Sebastian Buzynski, Rachel E. Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance // Peake Journal of Medical Imaging and Radiation Oncology. - 2015. - Vol. 59. - P. 300-305.

Zanardo M., Cozzi A., Trimboli R.M. et al. Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review // Insights into Imaging. - 2019. - Vol. 10. - P 76.

Travieso M. Aja et al. Utility of spectral mammography with contrast enhancement in the diagnosis of breast disease // Paper presented at ECR -Vienna - 2014.

Lobbesa M.B.I., Muldera H.K.P, Rouschb M. et al. Quantification of enhancement in contrast-enhanced spectral mammography using a custom-made quantifier tool (I-STRIP): A proof-of-concept study // European Journal of Radiology. - 2018. - Vol. 106. - P 114-121.

Tsigginou A., Gkali C., Chalazonitis A. et al. Adding the power of iodinated contrast media to the credibility of mammography in breast cancer diagnosis // Br J Radiol. - 2016. - Vol. 89. - P. 1067.

Houben I.P, Vanwetswinkel S., Kalia V. et al. Contrast-enhanced spectral mammography in the evaluation of breast suspicious calcifications: diagnostic accuracy and impact on surgical management //Acta Radiol. - 2019. - Vol. 60. - № 9. - P. 1110-1117.

Cheung Y-C., Juan Y.H., Lin Y.C. et al. Dual-energy contrast-enhanced spectral mammography: enhancement analysis on BI-RADS 4 non-mass microcalcifications in screened women // PLoS One - 2016. - Vol. 9. - e110162740.

Семиглазов В.Ф., Семиглазов В.В. Скрининг рака молочной железы // Практическая онкология. - 2010. - Т. 11. - № 2. - C. 61-62.

Pisano E.D., Gatsonis C., Hendrick E. et al. Diagnostic performance of digital versus film mammography for breast-cancer screening // N Engl J Med. - 2005. - Vol. 353. - P. 1773-1783.

Morris E.A., Liberman L., Ballon D.J. et al. MRI of occult breast carcinoma in a high-risk population // AJR Am J Roentgenol. - 2003. - Vol. 181. - P. 619-626.

Patel B.K., Hilal T., Covington M. et al. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy // Ann Surg Oncol. - 2018. - Vol. 25. - № 5. - P. 1350-1356.

Чёрная А.В., Новиков С.Н., Криворотько П.В. и др. Новые технологии при выявлении рака молочной железы - контрастная двухэнергетическая спектральная маммография // Медицинская визуализация. - 2019 - T. 2. - C. 49-61.

Рожкова Н.И., Бурдин И.И., Запирова С.Б. и др. Контрастная двухэнергетическая спектральная маммография // Исследования и практика в медицине. - 2015. - Т. 2. - № 4. - С. 82-87.

Covington M.F., Pizzitola V.J., Lorans R. et al. The Future of Contrast-Enhanced Mammography // AJR - 2018. - Vol. 210. - P. 1-9.

Blum K.S., Rubbert C., Mathys B. et al. Use of contrast enhanced spectral mammography for inframammary cancer staging: preliminary results // Acad. Radiol. - 2014. - Vol. 21. - Р. 1363-1369.

Lobbes M.B.I., Hecker J., Houben I.PL. et al. Evaluation of single-view contrast-enhanced mammography as novel reading strategy: a non-inferiority feasibility study // Eur Radiol. - 2019. - Vol. 29. - №11. -P 62116219.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2020